Effects of high-dose vitamin B6 therapy on microcytic and hypochromic anemia in hemodialysis patients

Takanobu Toriyama, Hiroshi Takahashi, Kazuyuki Sato, Nobuhiro Mimuro, Hirohisa Kawahara, Seiichi Matsuo, Atsushi Fukatsu

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)


In an attempt to treat hemodialysis patients suffering from microscopic and hypochromic anemia (MHA) and who are either sufficient or deficient in serum ferritin level, we investigated the effects of oral administration of vitamin B6 (VB6). Twenty-six patients with MHA undergoing long-term stable hemodialysis treatment were divided into three groups. There was no significant difference in the serum VB6 levels in these patients as compared with normal subjects before the study. Patients in group I, whose serum ferritin levels were normal, were orally administered 180mg of VB6 every day for 20 weeks. Patients in groups II and III, whose serum ferritin levels were far below normal (due to suspected iron deficiency anemia), were either administered iron alone (intravenous administrationof 40mg of iron for 12 consecutive dialysis treatments, for 4 weeks - group II) or both iron and VB6 (group III). There was significant improvement in the hematocrit, mean corpsular volume (MCV), and mean corpsular hemoglobin (MCH) in group I patients supporting the contention that this group of patients had pyridoxine responsive anemia (PRA). The number of sideroblasts in bone marrow in these patients, however, was significantly low when compared to that of the normal subjects. In addition, the combined therapy with iron and VB6 led to the longer-sustained improvement in hematocrit in patients with suspected iron deficiency anemia (group III) when compared to those treated with iron alone (group II). These data suggest that VB6 is useful in hemodialysis patients with MHA with either a sufficient or deficient serum ferritin level, and that the mechanisms of MHA in hemodialysis patients should be further investigated in relation to iron and VB6 metabolism.

Original languageEnglish
Pages (from-to)975-980
Number of pages6
JournalJapanese Journal of Nephrology
Issue number8
Publication statusPublished - 1993

All Science Journal Classification (ASJC) codes

  • Nephrology


Dive into the research topics of 'Effects of high-dose vitamin B6 therapy on microcytic and hypochromic anemia in hemodialysis patients'. Together they form a unique fingerprint.

Cite this